Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Covance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Covance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Covance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Covance Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Covance Inc, Medical Devices Deals, 2011 to YTD 2017 11
Covance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Covance Inc, Pharmaceuticals & Healthcare, Deal Details 14
Private Equity 14
Chicago Growth Partners Acquires Caprion Proteomics For US$29 Million 14
Partnerships 15
Emulate Enters into Agreement with Covance 15
Motif Bio Enters into Agreement with Covance 16
Covance Enters into Co-Development Agreement with Sihuan Pharma 17
Covance Enters into Co-Development Agreement with Novartis Institutes for BioMedical Research 18
Covance Enters into Research Agreement with Frenova Renal Research 19
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 20
Covance And Royal Liverpool and Broadgreen University Hospitals Enter Into Agreement To Offer Clinical Trials 21
GNS Healthcare Enters Into Co-Development Agreement With Covance 22
Bayer HealthCare Enters Into Agreement With Covance 23
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 24
Covance Enters Into Research Agreement With Institute for Systems Biology For Tumor Biology 25
Ingenuity Systems Enters Into Research Collaboration With Covance Genomics 26
Takeda Enters Into Co-Development Agreement With Covance 27
Debt Offering 28
Covance Completes Private Placement Of Notes Due 2023 For US$90 Million 28
Covance Completes Private Placement Of Notes Due 2018 For US$15 Million 29
Covance Completes Private Placement Of Notes Due 2020 For US$50 Million 30
Covance Completes Private Placement Of Notes Due 2025 For US$95 Million 31
Asset Transactions 32
LabCorp Acquires High-Complexity Genomic Lab From Covance 32
Acquisition 33
LabCorp Acquires Chiltern International for USD1.2 Billion 33
Chiltern International Acquires Integrated Development Associates 35
LabCorp Acquires Covance for USD6.1 Billion 36
Chiltern International Acquires Pacific Clinical Research 38
BioLegend Acquires Covance Antibody Services from Covance 39
Chiltern Acquires Ockham, Contract Research Organization 40
Covance Acquires Medaxial 41
Kester Capital Sells Its Stake In Chiltern For US$220 Million 42
Smithers Viscient Services Completes Acquisition Of Environmental Sciences From Covance 43
Covance Acquires Trac Microbiology, Microbiology And Chemistry Laboratory 44
Chiltern International Acquires Additional Stake In Endpoint 45
Covance Inc – Key Competitors 46
Covance Inc – Key Employees 47
Covance Inc – Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 53
Product News 53
Sep 05, 2016: PCI Biotech Announces First subject dosed in the fimaVACC phase I study 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54
Covance Inc, Pharmaceuticals & Healthcare, Key Facts 2
Covance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Covance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Covance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Covance Inc, Deals By Therapy Area, 2011 to YTD 2017 10
Covance Inc, Medical Devices Deals, 2011 to YTD 2017 11
Covance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Chicago Growth Partners Acquires Caprion Proteomics For US$29 Million 14
Emulate Enters into Agreement with Covance 15
Motif Bio Enters into Agreement with Covance 16
Covance Enters into Co-Development Agreement with Sihuan Pharma 17
Covance Enters into Co-Development Agreement with Novartis Institutes for BioMedical Research 18
Covance Enters into Research Agreement with Frenova Renal Research 19
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 20
Covance And Royal Liverpool and Broadgreen University Hospitals Enter Into Agreement To Offer Clinical Trials 21
GNS Healthcare Enters Into Co-Development Agreement With Covance 22
Bayer HealthCare Enters Into Agreement With Covance 23
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 24
Covance Enters Into Research Agreement With Institute for Systems Biology For Tumor Biology 25
Ingenuity Systems Enters Into Research Collaboration With Covance Genomics 26
Takeda Enters Into Co-Development Agreement With Covance 27
Covance Completes Private Placement Of Notes Due 2023 For US$90 Million 28
Covance Completes Private Placement Of Notes Due 2018 For US$15 Million 29
Covance Completes Private Placement Of Notes Due 2020 For US$50 Million 30
Covance Completes Private Placement Of Notes Due 2025 For US$95 Million 31
LabCorp Acquires High-Complexity Genomic Lab From Covance 32
LabCorp Acquires Chiltern International for USD1.2 Billion 33
Chiltern International Acquires Integrated Development Associates 35
LabCorp Acquires Covance for USD6.1 Billion 36
Chiltern International Acquires Pacific Clinical Research 38
BioLegend Acquires Covance Antibody Services from Covance 39
Chiltern Acquires Ockham, Contract Research Organization 40
Covance Acquires Medaxial 41
Kester Capital Sells Its Stake In Chiltern For US$220 Million 42
Smithers Viscient Services Completes Acquisition Of Environmental Sciences From Covance 43
Covance Acquires Trac Microbiology, Microbiology And Chemistry Laboratory 44
Chiltern International Acquires Additional Stake In Endpoint 45
Covance Inc, Key Competitors 46
Covance Inc, Key Employees 47
Covance Inc, Other Locations 48
Covance Inc, Subsidiaries 51